Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san diego blog main
3
×
san diego top stories
akcea therapeutics
alnylam pharmaceuticals
biotech
boston
boston blog main
boston top stories
clinical trials
drugs
fda
hereditary transthyretin amyloidosis
inotersen
national top stories
new york blog main
new york top stories
patisiran
tafamidis
alnylam
arena pharmaceuticals
artie suckow
barry greene
boston university
dan ollendorf
drug delivery
dtx pharma
european medicines agency
financing
harvard pilgrim health care
institute for clinical and economic review
jeff friedman
john berk
john grundy
mary o'donnell
onpattro
pfizer
regeneron pharmaceuticals
rna
What
rna
3
×
alnylam
fda
medicine
uses
way
advance
ago
approve
approves
awaits
biological
biologics
cells
considered
crossed
decades
decision
deliver
discovered
diseases
drug
drugs
dtx
ema
employ
europe
fingers
follows
friday
gene
harmful
historic
hits
hitting
interference
make
medicines
method
molecules
Language
unset
Current search:
rna
×
" san diego blog main "
×
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision